Life Insurance Policy: Recovered From Covid? Wait Three Months To Buy New Policy – India.com

New Delhi: The insurers have made the standard waiting period applicable to coronavirus cases just like other ailments in India. Now, people who have recovered from Covid-19 will have to wait three months to get a new life insurance policy. In the case of almost all the other ailments, the recovered patients have to wait for a specific period before buying a new policy. This rule was set in place to gauge the risk before selling a policy.Also Read – South Africa To Host Australia, England in 2023, Confirms Graeme Smith

The new change in the case of coronavirus is true only for life insurance policies. In the case of other policies, the rules are as it is. The new decision has been taken keeping in mind the high mortality in case of coronavirus infections. Also Read – With COVID Guidelines In Place, Thousands Witness Makarajyoti At Sabarimala Temple | See Pics

Reinsurers have asked insurance companies to bring coronavirus infection cases also under the standard waiting period norms as high mortality rates have impacted the reinsurance business. The waiting period is about one to three months, they added. Also Read – COVID-19: WHO Scientists Find Two New COVID-19 Drugs, All You Need to Know

Reinsurance players provide cover for insurance policies issued by insurers. Sumit Bohra, President of the Insurance Brokers Association of India (IBAI), said Indian insurers do not have the capacity to write all these risks. So, most of the insurance policies that are above Rs 10-20 lakh are reinsured and the reinsurers want “good risk to come into the system” due to which the waiting period has been made applicable for coronavirus infection cases also, he noted.

“The term insurance plans are reinsured by the life insurance companies and given the last two years and the kind of experience that the industry has seen in terms of claims, this is a requirement that has been raised and put in place by the reinsurance companies. So we need to have this rule coming into force with immediate effect,” Karthik Raman, Product Head of Ageas Federal Life, said.

Raman said insurance companies already have the waiting period requirement for various other ailments and coronavirus infection is one more ailment added to that list.

“It is a standard practice to have a waiting period. It is not just our country, it is worldwide and COVID comes under this practice,” he said.

According to Bohra, coronavirus infection has also been included in the list of ailments where the waiting period will be applicable since the mortality rate is high due to the infection.

“Previously, the mortality rate was less and there was acceptance for more risk. Any amount of premium is not good enough to pay the claims if the mortality rate is going to be high. With COVID, it is not like a simple cold or flu.

“It is damaging other parts/ organs of the body as well, especially the lungs. So, it is difficult to gauge the survival rate if a policy is being issued for a longer period of time,” Bohra said.

Yogesh Agarwal, Founder and CEO of Onsurity, said, “in our understanding, we have seen insurers asking for a one month kind of waiting period. It is part of a risk management strategy because of what had happened during the second COVID wave”.

Term life insurance products are driven not only by the insurers but by the reinsurers as well in the ecosystem.

“We have seen that reinsurers have not been able to do good business over the last one-and-a-half years since the COVID pandemic,” he said.

Agarwal said the waiting period condition for people who have recovered from coronavirus infection will be applicable only on life insurance policies, and not health. Also, it will be applicable to only new retail customers and the existing policyholders will not be impacted in any manner.

During 2020-21, the country’s largest life insurer LIC gave over Rs 442 crore as a reinsurance premium, up from Rs 327 crore in the previous fiscal. Private sector players together ceded Rs 3,909 crore as a premium towards reinsurance, up from Rs 3,074 crore in the preceding financial year.